^
    CANCER:

    Ampulla of Vater Carcinoma





    Show legend
    Group by Gene:
    0
    PD-L1 inhibitor
    durvalumab
    1
    VEGF-A inhibitor
    bevacizumab
    2
    TrkB receptor inhibitor, TrkC kinase inhibitor, TrkA receptor inhibitor
    larotrectinib
    3
    KRAS G12C inhibitor
    sotorasib
    adagrasib
    4
    MEK inhibitor, BRAF inhibitor
    trametinib + dabrafenib
    5
    mTOR inhibitor
    everolimus
    6
    MDM2-p53 antagonist
    BI 907828
    7
    DNA synthesis inhibitor, Bcl2 inhibitor, Tubulin inhibitor
    gemcitabine + albumin-bound paclitaxel
    cisplatin + gemcitabine + albumin-bound paclitaxel
    8
    RET inhibitor
    selpercatinib
    9
    Chemotherapy
    FOLFIRINOX
    10
    Folate analog, Thymidylate synthase inhibitor
    5-fluorouracil + leucovorin calcium
    11
    MEK inhibitor
    MEK inhibitor
    12
    TrkB receptor inhibitor, TrkC kinase inhibitor, ROS1 inhibitor, TrkA receptor inhibitor, ALK inhibitor, JAK2 inhibitor, TNK2 inhibitor
    entrectinib
    13
    HER2 inhibitor, HER4 inhibitor, EGFR inhibitor
    afatinib
    14
    HER2 inhibitor, CDK4 inhibitor, CDK6 inhibitor, HER2 dimerization inhibitor
    palbociclib + pertuzumab + abemaciclib + ribociclib + trastuzumab / hyaluronidase-oysk
    15
    cRAF inhibitor, MEK inhibitor, BRAF inhibitor
    binimetinib + encorafenib
    16
    DNA synthesis inhibitor
    gemcitabine
    No biomarker
    KRAS G12C
    NTRK1 fusion
    BRAF V600E
    BRAF D594G
    NTRK3 fusion
    RET fusion
    HER-2 G660D + HER-2 S310F
    KRT7 expression
    KRT7 expression + MUC1 expression
    HER-2 mutation + CDK6 mutation
    PIK3CA mutation
    NTRK2 fusion
    NRAS mutation + BRAF mutation
    MDM2 amplification
    MUC2 negative